Immunogen Inc. buy BMO Capital Markets
Start price
01.08.23
/
50%
€16.22
Target price
01.08.24
€23.69
Performance (%)
78.61%
End price
02.08.24
-
Summary
This prediction is currently being closed. With a performance of 78.61% the BUY prediction by BMO_Capital_Markets is a big success. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Immunogen Inc. | - | - | - |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Immunogen Inc. diskutieren
ImmunoGen, Inc. (NASDAQ: IMGN) had its price target raised by analysts at BMO Capital Markets from $25.00 to $26.00. They now have an "outperform" rating on the stock.
Ratings data for IMGN provided by MarketBeat
In the thread Trading Immunogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten